ClinicalTrials.gg
RecruitingNCT07715006Updated Aug 11, 2026

Dorsal Root Electrical Stimulation in Children With Cerebral Palsy

An interventional study of Constant Current Stimulator and Cadwell Guardian System in Cerebral Palsy (CP), Cerebral Palsy and Spasticity, sponsored by Martin Piazza. Recruiting at 1 site in United States. Open to participants aged 3 Years to 14 Years. Per ClinicalTrials.gov, last updated 2026-08-11.

Sponsored by Martin Piazza · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Started Jul 2026; still recruiting 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
3 Years to 14 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 372 studies in Cerebral Palsy with a site in United States — 74 open to participants now, 102 under way, none of them phase 3. Cerebral Palsy · United States.

Planned enrollment
192nd of 296
15 · median 25
Started
2026
with 23 others
No phase
218 of 372
49 open now
Primary completion
2029-11
later than 90 of 101 live
Registered
367th of 372
by date

Among the 372 studies in Cerebral Palsy with a site in United States, this one is the 192nd largest by planned enrollment of the 296 interventional ones that give a count, is one of 24 that started in 2026, is one of 218 with no phase, reaches primary completion later than 90 of the 101 other live ones, and was the 367th registered.

Cerebral Palsy

1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.

Browse Cerebral Palsy studies →

Open to participants now

74 of the 372 studies in Cerebral Palsy with a site in United States are open now. Recruiting first, the newest first:

68 more — sign in →

All 74 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.

This study: 3 Years to 14 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 372 studies in Cerebral Palsy with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to evaluate whether dorsal root electrical stimulation could reduce spasticity in children with cerebral palsy (CP).

Read the detailed description

The investigators will recruit participants with CP requiring selective dorsal rhizotomy (SDR) surgery. During SDR, spastic dorsal roots are routinely identified by electrically stimulating each root at low frequency (1 Hz) and measuring the resulting muscle response via electromyography - a procedure called "clinical test stimulation." Dorsal roots that produce an abnormally large and widespread compound muscle action potential (CMAP) are classified as spastic. In this study, the investigators will superimpose higher-frequency dorsal root stimulation (40-5000 Hz) on top of this standard clinical test stimulation and assess whether it suppresses the abnormal large CMAP.

03

Conditions studied

  • Cerebral Palsy (CP)
  • Cerebral Palsy
  • Spasticity
  • Spasticity Due to Cerebral Palsy

Keywords

  • Dorsal root electrical stimulation
04

Who can participate

Ages eligible
3 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children ages 3 to 14
  • Diagnosis of Cerebral Palsy
  • Require an SDR as determined by the multidisciplinary movement disorders team
  • Confirmation that subjects' terms of insurance coverage for their standard of care procedure will not be altered by study enrollment.

Exclusion criteria

Exclusion Criteria:

  • No exclusion criteria
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Cerebral Palsy Group

    The investigators will use the DS8R to directly deliver electrical stimulation with hook electrodes to the dorsal roots while testing the spasticity of individual dorsal roots.

    Device: Constant Current Stimulator · Device: Cadwell Guardian System

Interventions

  • DeviceConstant Current Stimulator

    The DS8R is an external isolated stimulator system used in human research (DS8R), delivers controlled electrical pulses with adjustable stimulation parameters.

  • DeviceCadwell Guardian System

    The Cadwell Guardian System is a clinical intraoperative system used to deliver stimulation in the dorsal root during SDR.

06

What researchers measure

Primary outcomes

  1. Peak-to-peak amplitude of the dorsal root reflex

    The investigators will assess whether dorsal root electrical stimulation at frequencies (40-5000Hz) can normalize the abnormally large muscle response to electrical stimulation of the same dorsal root at low frequencies that is a signature of spasticity in CP. The investigators will measure the peak-to-peak amplitude of the dorsal root reflex with intramuscular EMGs. Succes criteria: A 20% reduction in the peak-to-peak amplitude of the spinal reflex

    Time frame: In session during the surgery (1 session)

07

Study locations

1 of 1 sites recruiting
  • UPMC Children's Hospital of Pittsburgh
    Pittsburgh, Pennsylvania 15224, United States
    Recruiting
    • Bailey G McDonald, BS · Contactmcdonaldbm3@upmc.edu · 412-692-9966
    • Martin G Piazza, MD · Contactpiazzamg@upmc.edu
    • Martin G Piazza, MD · Principal investigator
    • Genis Prat-Ortega, PhD · Sub investigator
    • Taylor Abel, MD · Sub investigator
    • Jeffrey Balzer, PhD · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2026 (actual). Primary completion is estimated for Nov 2029, 39 months after the start.

Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 39 months is above that.

Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 8, 2026
First posted
Jul 20, 2026
StartActual
Jul 16, 2026
Primary completionEst.
Nov 1, 2029
CompletionEst.
Dec 2029
Last update
Aug 11, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07715006
Lead sponsor
Martin Piazza
Responsible party
Martin Piazza (Assistant Professor, Pediatric Neurosurgery, University of Pittsburgh) — Sponsor-investigator
First posted
Jul 20, 2026
Start date
Jul 16, 2026
Primary completion
Nov 1, 2029 (estimated)
Completion
Dec 2029 (estimated)
Last update
Aug 11, 2026

Study contacts

Bailey McDonald, BS
Contact
mcdonaldbm3@upmc.edu
412-692-9966
Martin G Piazza, MD
Contact
piazzamg@upmc.edu
Martin G Piazza, MD
principal investigator · University of Pittsburgh

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion